Clinical Trial Update: GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU) [NA]

View source ↗

Summary

This clinical trial update reports the completion of GLUCOSAFE 2, a tool for nutritional management and insulin therapy in ICU patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Hyperglycemia
• Hypoglycemia
• Protein Deficiency
• Protein-energy Malnutrition

Drugs mentioned

• GLUCOSAFE 2

Snippet

Sponsor: HEIDEGGER CP | Conditions: Critical Illness, Energy Supply; Deficiency, Severe | NA | Status: COMPLETED